Clínica Las Condes S.A. EBIT

Clínica Las Condes S.A. (LAS-CONDES.SN) currently reports a EBIT of $-50B as of June 2026. That compares with $-110B in the prior-year period — up 55.9% year over year. That is below the sector sector average of $2.6T. Use the charts on this page to explore Clínica Las Condes S.A.'s EBIT history and peer comparisons.

Clínica Las Condes S.A.'s EBIT increased from $-110B to $-50B — a 55.9% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Clínica Las Condes S.A.'s EBIT of $-50B is lower than the its sector sector average of $2.6T. That is roughly 101.9% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

Clínica Las Condes S.A. reported $-50B in EBIT as of June 2026. That compares with $-110B in the prior-year period — up 55.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-50B, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $2.6T. From there, open related valuation or income-statement pages for Clínica Las Condes S.A., and consider following LAS-CONDES.SN for alerts when major investors trade the stock.